Economic evaluation on infant hepatitis B vaccination combined with immunoglobulin in China, 2013

References

• Dai Z-C, Qi G-M, editors. Virual Hepatitis in China(Part One): Seroepidemiological Survey in Chinese Population, 1992–1995 Beijing: Scientific and Technical Documentation Press; 1997.
   Google Scholar
• WHO. Hepatitis B Vaccines - WHO Pasition Paper. Weekly Epidemiological Record 2009; 84:405-20; PMID:19817017
   PubMedGoogle Scholar
• Zou H-B, Chen Y, Duan Z-P, Zhang H. Protective effect of hepatitis B vaccine combined with two-dose hepatitis B immunoglobulin on infants born to HBsAg-positive mothers. PloS one 2011; 6(10):e26748; PMID:22053208; http://dx.doi.org/10.1371/journal.pone.0026748
   PubMed Web of Science ®Google Scholar
• Lee C, Gong Y, Brok J, Boxall EH, Gluud C. Effect of hepatitis B immunisation in newborn infants of mothers positive for hepatitis B surface antigen: systematic review and meta-analysis. Bmj 2006; 332(7537):328-36; PMID:16443611; http://dx.doi.org/10.1136/bmj.38719.435833.7C
   PubMed Web of Science ®Google Scholar
• Zhao Zhang CC, Zhe Li, Ying-Hua W, Xiao-Min X. Individualized management of pregnant women with high hepatitis B virus DNA levels. World J Gastroenterol 2014; 20(34):12056-61; PMID:25232243; http://dx.doi.org/10.3748/wjg.v20.i34.12056
   PubMed Web of Science ®Google Scholar
• Lu SQ, McGhee SM, Xu X, Cheng J-Q, Fielding R. Economic evaluation of universal newborn hepatitis B vaccination in China. Vaccine 2013; 31(14):1864-9; PMID:23384752; http://dx.doi.org/10.1016/j.vaccine.2013.01.020
   PubMed Web of Science ®Google Scholar
• Lu J-J. Economic evaluation of hepatitis B immunization strategy among newborns in shandong [D] JIinan: Shandong University 2013.
   Google Scholar
• Li S-P, Ma D-S, Wang J. Review of economic evaluation on HBV vaccination strategy in China. Chinese Health Economics 2011; 30(3):84-6.
   Google Scholar
• Yin J, Ji Z, Liang P, Wu Q, Cui F, Wang F, Liang X, Zhuang G. The doses of 10 mug should replace the doses of 5 mug in newborn hepatitis B vaccination in China: A cost-effectiveness analysis. Vaccine 2015; 33(31):3731-8; PMID:26057138; http://dx.doi.org/10.1016/j.vaccine.2015.05.082
   PubMed Web of Science ®Google Scholar
• An S-Y, Jia H, Han Y, Guo J-Q. Mata anlysis on immune effect of different dosage of recombinant yeast hepatitis B vaccine. Ch J Health Stat 2009; 26(4):398-9.
   Google Scholar
• Liang Z-L, Li H-M, Zhuang H. Research on the Hepatitis B vaccine immunization effect factors and boost vaccination strategy. Ch J Epidemiol 2007; 28(4):313-4; PMID:17850691
   PubMedGoogle Scholar
• Zheng H, Wang FZ, Zhang GM, Cui FQ, Wu ZH, Miao N, Sun XJ, Liang XF, Li L. An economic analysis of adult hepatitis B vaccination in China. Vaccine 2015; 33:6831-9; PMID:26384449; http://dx.doi.org/10.1016/j.vaccine.2015.09.011
   PubMed Web of Science ®Google Scholar
• http://www.inflation.eu/inflation-rates/china/historic-inflation/cpi-inflation-china.aspx [acessed by 2014.8.29].
   Google Scholar
• http://data.stats.gov.cn/workspace/index?m=hgnd [accessed by 2014.8.29].
   Google Scholar
• http://data.stats.gov.cn/workspace/index;jsessionid=C4261DC501F1665250ED17184314349D?m=hgnd [accessed by 2015.4.29].
   Google Scholar
• Shen Y-H, Cui L, Zhang W, Xing Y, Liu W-D. Development of epidemioiogical compartmental model for HBsAg carrier rate and control policy analysis in Beijing. Inter J Virol 2012; 19(3):97-101.
   Google Scholar
• Hutton DW, So SK, Brandeau ML. Cost-effectiveness of nationwide hepatitis B catch-up vaccination among children and adolescents in China. Hepatology 2010; 51(2):405-14; PMID:19839061; http://dx.doi.org/10.1002/hep.23310
   PubMed Web of Science ®Google Scholar
• Choi HJ, Ko SY, Choe WH, Seo YS, Kim JH, Byun KS, Kim YS, Kim SU, Baik SK, Cheong JY, et al. Clinical features of acute viral hepatitis B in Korea: a multi-center study. Korean J Hepatol 2011; 17(4):307-12; PMID:22310795; http://dx.doi.org/10.3350/kjhep.2011.17.4.307
   PubMedGoogle Scholar
• Kim SY, Billah K, Lieu TA, Weinstein MC. Cost effectiveness of hepatitis B vaccination at HIV counseling and testing sites. Am J Prevent Med 2006; 30(6):498-506; PMID:16704944; http://dx.doi.org/10.1016/j.amepre.2006.01.017
   PubMed Web of Science ®Google Scholar
• Diseases CSoHaCSoI, Association. CM. The Guideline of Prevention and Treatment for Chronic Hepatitis B (2010 Version) [J]. Ch J Clin Hepatol 2011; 27(1):1-16.
   Google Scholar
• Epidemiology and Prevention of Vaccine-preventable Diseases (eleventh edition): CDC; 2009.
   Google Scholar
• Zhou F, Reef S, Massoudi M, Papania MJ, Yusuf HR, Bardenheier B, Zimmerman L, McCauley MM. An economic analysis of the current universal 2-dose measles-mumps-rubella vaccination program in the United States. JID 2004; 189(suppl1):S131-45; PMID:15106102; http://dx.doi.org/10.1086/378987
   PubMedGoogle Scholar
• Population Cencus Office under the State Council, Department of Population and Employment Statistics National Bureau of Statistics. Tabulation on the 2010 Population Census of the People's Republic of China[M]. 2012.
   Google Scholar
• Yan Chen BS, Wang J, Zheng Y. A clinical pathway in idiopathic thrombocytopenic purpura application of hospitalized patients. China Medical Engineering 2013; 21(1): 154-5; http://www.stats.gov.cn/tjsj/ndsj/2011/indexch.htm.
   Google Scholar
• Yan Chen BS, Jiaojiao W, Zheng Y A clinical pathway in idiopathic thrombocytopenic purpura application of hospitalized patients. Ch Med Eng 2013; 21(1):154-5.
   Google Scholar
• Yao F-Y, Zhu Y. Analysis on Adverse Events Following Immunization and the disease burden in Pinghu City, 2010-2011. Shanghai J Prevent Med 2013; 25(2):71-3.
   Google Scholar
• http://data.stats.gov.cn/workspace/index;jsessionid=C4261DC501F1665250ED17184314349D?m=hgnd [accessed 2015.1.8].
   Google Scholar
• General Office of the National Development and Reform Commission. The notification on the factory price of 14 vaccines in explored program on immunization. 2009.
   Google Scholar
• Ling C. A analysis on the waste rate of EPI vaccines in China. China Prac Med 2013; 8(21):275-6.
   Google Scholar
• Zilian Y. The vaccine loss monitoring in Jiangdong District, Ningbo. Strait J Prey Med 2006; 12(5):57-8.
   Google Scholar
• Yu Wenzhou YJ, Cui G, Jin S, Wang J, Tao Z. Study on the reasonable cost of national immunization program in some regions of China. Ch J Vaccin Immunizat 2006; 12(4):280-5.
   Google Scholar
• http://www.chinesegraduate.com/news/view/2011/01/14/employee-benefits-in-china [accessed by 2015.3.13].
   Google Scholar
• http://www.gov.cn/gzdt/2012-11/29/content_2278530.htm [accessed 2015.1.6].
   Google Scholar
• http://service2.bjpc.gov.cn/bjpc/mediprice/MedicalService2.jsp [acessed 2014.8.20].
   Google Scholar
• Feng W. Establishment of the reference serum system about HBV markers and comparison of the diagnositic effect between six kinds of domestic HBV kit. 2007.
   Google Scholar
• Ma Jingchen QS, Wang F, Yu T, Zhang W, Zhao S, Zhang Y. Evaluation of 5 kinds of China-made enzyme immuoassay kits for antibody to hepatitis B virus core antigen detection. Ch J Vaccin Immunizat 2009; 15(5):400-3; PMID:20084963
   PubMedGoogle Scholar
• Demirjian A, Levy O. Safety and efficacy of neonatal vaccination. Eur J Immunol 2009; 39(1):36-46; PMID:19089811; http://dx.doi.org/10.1002/eji.200838620
   PubMed Web of Science ®Google Scholar
• Kabira A, Alavianb S-M, Ahanchic N, Malekzadeh R. Combined passive and active immunoprophylaxis for preventing perinatal transmission of the hepatitis B virus in infants born to HBsAg positive mothers in comparison with vaccine alone. Hepatology Research 2006; 36(4):265-71; PMID:16965939; http://dx.doi.org/10.1016/j.hepres.2006.08.001
   PubMed Web of Science ®Google Scholar
• Rui Y-J, Song W-Y, Chen J, Zhou Y-H, Hu Y-L, Wang Z-Q. Evaluation for effects for routine administration of hepatitis B vaccine and hepatitits B immunoglobulin on prevention mother-to-infant transmission of HBV-inffected mother with negative HBeAg. J Practical Obstetric Gynecol 2013; 29(7):506-8.
   Google Scholar
• Lao TT, Cheung KL, Wong V. Hepatitis B vaccine response among infants born to hepatitis B surface antigen-positive women. Vaccine 2015; 33(1):15-6; PMID:25017181; http://dx.doi.org/10.1016/j.vaccine.2014.05.036
   PubMed Web of Science ®Google Scholar
• Yang YJ, Liu CC, Chen TJ, Lee MF, Chen SH, Shih HH, Chang MH. Role of hepatitis B immunoglobulin in infants born to hepatitis B e antigen-negative carrier mothers in Taiwan. Pediat Infect Dis J 2003; 22(7):584-8; PMID:12867831
   PubMed Web of Science ®Google Scholar
• Liu C-P, Zeng Y-L, Zhou M, Chen LL, Hu R, Wang L, Tang H. Factors associated with mother-to-child transmission of hepatitis B virus despite immunoprophylaxis. Int Med 2015; 54(7):711-6; PMID:25832930; http://dx.doi.org/10.2169/internalmedicine.54.3514
   PubMed Web of Science ®Google Scholar
• Zhang L. Immunoprophylaxis Efficacy of Mother-to-Child Transimission of Hepatitis B Virus and Immunity effects of Inoculating Hepatitis B Vaccine [D] Changsha: Wu Han University 2013.
   Google Scholar
• Sylvie Ranger-Rogez FD. Hepatitis B mother–to–child transmission. Future-Drugs 2004; 2(1):133-45.
   Google Scholar
• Muhammad U, Hamama-tul-Bushra, Shifa U, Khan HA. HBV perinatal transmission. Inter J Hepatol 2013; 2013:875791.
   PubMedGoogle Scholar
• Mendy M, Peterson I, Hossin S, Peto T, Jobarteh ML, Jeng-Barry A, Sidibeh M, Jatta A, Moore SE, Hall AJ, et al. Observational study of vaccine efficacy 24 years after the start of hepatitis B vaccination in two Gambian villages: no need for a booster dose. PloS one 2013; 8(3):e58029; PMID:23533578; http://dx.doi.org/10.1371/journal.pone.0058029
   PubMed Web of Science ®Google Scholar
• Mast EE, Weinbaum CM, Fiore AE, Alter MJ, Bell BP, Finelli L, Rodewald LE, Douglas JM Jr, Janssen RS, Ward JW, Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC). A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults. MMWR Recomm Rep 2006; 55(RR-16):1-33; PMID:17159833
   PubMedGoogle Scholar
• Zheng H, Cui FG, Gong XH, Wang FZ, Chen YS, Wu ZH, Wang HG, Li L, Luo HM, Liang XF. Staus of the hepatitis B virus surface antigen and e antigen prevalence among reproductive women in China. Ch J Vaccin Immunizat 2010; 16(6):496-9.
   Google Scholar
• Ranger-Rogez S & Denis F. Hepatitis B mother to child transmission. Anti-infect Ther 2004; 2(1):133-26; http://dx.doi.org/10.1586/14787210.2.1.133
   PubMedGoogle Scholar
• Leung N. Chronic hepatitis B in Asian women of childbearing age. Hepatology international 2009; 3 (Suppl 1):24-31; PMID:19669243; http://dx.doi.org/10.1007/s12072-009-9142-1
   PubMed Web of Science ®Google Scholar
• Wang F-Z, Cui F-Q. The immunoprophylaxis strategy of prevention mother to child transmission of hepatitis B virus. Ch J Vaccin Immunizat 2014; 20(4):355-9.
   Google Scholar
• Edmunds WJ, Medley GF, Nokes DJ, O'Callaghan CJ, Whittle HC, Hall AJ. Epidemiological patterns of hepatitis B virus (HBV) in highly endemic areas. Epidemiol Infect 1996; 117(2):313-25; PMID:8870629; http://dx.doi.org/10.1017/S0950268800001497
   PubMed Web of Science ®Google Scholar
• Registry CLT. The annual scientific report of China liver transplantation, 2011, 2011.
   Google Scholar
• Edmunds WJ, Medley GF, Nokes DJ, Hall AJ, Whittle HC. The influence of age on the development of the hepatitis B carrier statel. Proc Biol Sci/ The Royal Society 1993; 253(1337):197-201; PMID:8397416; http://dx.doi.org/10.1098/rspb.1993.0102
   PubMed Web of Science ®Google Scholar
• Chang M-H. Natural history and clinical management of chronic hepatitis B virus infection in children. Hepatol Inter 2008; 2(Supplement 1):28-36; http://dx.doi.org/10.1007/s12072-008-9050-9
   PubMed Web of Science ®Google Scholar
• Jia Y, Li L, Cui F, Zhang D, Zhang G, Wang F, Gong X, Zheng H, Wu Z, Miao N, et al. Cost-effectiveness analysis of a hepatitis B vaccination catch-up program among children in Shandong Province, China. Hum Vaccin Immunotherapeut 2014; 10(10):2983-91; PMID:25483678; http://dx.doi.org/10.4161/hv.29944
   PubMed Web of Science ®Google Scholar
• Wen-yuan Ze. Immunology (version 2): Shanghai science and technology literature press; 2001.
   Google Scholar
• Fan L, Owusu-Edusei K, Schillie SF, Murphy TV. Cost-effectiveness of active-passive prophylaxis and antiviral prophylaxis during pregnancy to prevent perinatal hepatitis B virus infection. Hepatology 2015; http://dx.doi.org/10.1002/hep.28310
   Web of Science ®Google Scholar
• Hoerger TJ, Schillie S, Wittenborn JS, Bradley CL, Zhou F, Byrd K, Murphy TV. Cost-effectiveness of hepatitis B vaccination in adults with diagnosed diabetes. Diabetes care 2013; 36(1):63-9; PMID:22933435; http://dx.doi.org/10.2337/dc12-0759
   PubMed Web of Science ®Google Scholar
• Wong WW, Woo G, Heathcote EJ, Krahn M. Disease burden of chronic hepatitis B among immigrants in Canada. Can J Gastroenterol 2013; 27(3):137-47; PMID:23516678
   PubMed Web of Science ®Google Scholar
• Toy M, Onder FO, Idilman R, Kabacam G, Richardus JH, Bozdayi M, Akdogan M, Kuloglu Z, Kansu A, Schalm S, et al. The cost-effectiveness of treating chronic hepatitis B patients in a median endemic and middle income country. Eur J Health Econ 2012; 13:663-76; PMID:22815098; http://dx.doi.org/10.1007/s10198-012-0413-8
   PubMed Web of Science ®Google Scholar
• QIAO Fuyu WM. A study on direct economic burden of diseases related to hepatitis B viral infection in Xicheng district of Beijing. Capital J Public Health 2011; 5(6):247-51.
   Google Scholar
• Yuanyuan Z. Economic burden of hepatitis B inpatients with urban employee basic medical insurance in tianjin [D] Tianjin: School of Pharmaceutical Science and Technology, TJU 2012.
   Google Scholar
• LAO Guoqin WJ, Yong WU. Economic benefit of interferon in treatment of chronic hepatitis B infection. China Pharmacy 2006; 17(16):1223-5.
   Google Scholar
• Liang S, Zhang S, Ma Q, Xiao H, Xie X, Mei S, Hu D, Zhou B, Li B, Cui F, et al. Study on the direct economic burden of hepatitis B and its economic impact on family in Shenzhen city. Ch Health Economics 2011; 30(2):56-8.
   Google Scholar
• Xiaoqiang L. Economic burden and quality of life in patients with hepatitis B -relatedrelated Diseases [D] Ningxia: Ningxia Medical University 2012.
   Google Scholar
• Wujie S. The study on economic burden of hepatitis B related disease in Changzhi city [D] Taiyuan: Shan Xi Medical University 2011.
   Google Scholar
• Lu J, Xu A, Wang J, Zhang L, Song L, Li R, Zhang S, Zhuang G, Lu M. Direct economic burden of hepatitis B virus related diseases evidence from Shandong, China. BMC Health Serv Res 2013; 13(37); http://dx.doi.org/10.1186/472-6963-13-37
   Google Scholar
• Ma Q, Zou Y, Zhang S, Liang S, Xiao H, Xie X, Mei S, Jia W, Zhang Y, Cui F, et al. Analysis on the direct economic burden and influence factors of HBV-related diseases in Guangzhou. Ch in Prev Med 2011; 12(5):383-6.
   Google Scholar
• Jian C, Ma Q, Zou Y, Liu H, Lu J, Zhang Z, Zhang S, Jia W. A study on Hepatitis B'S economic burden and impact factors analysis in guangdong province. Ch Primary Health Care 2011; 25(7):7-9.
   Google Scholar
• Chen X, Chen H, Larry L, Gauri BS, Alison TM. Economic benefit of lamivudine in treatment of chronic hepatitis B virus infection. Ch Heparol 2002; 7(2):79-81.
   Google Scholar
• Hu M & Chen W. Assessment of total economic burden of chronic hepatitis B (CHB)-related diseases in Beijing and Guangzhou, China. Value Health 2009; 12(Suppl 3): S89-92; PMID:20586991; http://dx.doi.org/10.1111/j.1524-4733.2009.00636.x
   PubMedGoogle Scholar
• Wang D, Song S, Yuan J, Xiu D, Yang X, Zhang T. Influence of preoperative status on the cost of liver transplantation. Ch J Gen Surg 2004; 13(8):606-8.
   Google Scholar
• Qin G. Study on disease burden of liver or renal transplantation in a organ transplantation center [D] Changsha: Central South University 2011.
   Google Scholar
• Song Jianhua FK. Study on liver transplantation operation time chroice and treatment cost. J North Sichuan Med College 2007; 22(5):464-6.
   Google Scholar
• Ma Q. Study on the Economic burden of Hepatitis B related Diseases in Guangzhou and the Strategies of Hepatitis B Vaccination for Population Aged 1˜14 in China [D] guangdong: Guangdong Pharmaceutical University 2011.
   Google Scholar
• http://data.stats.gov.cn/search/keywordlist2 [accesed in 2015.1.5].
   Google Scholar